发明名称 Use of pnp inhibitors such as forodesine in combination with alkylating agents for treating hematologic cancers
摘要 <p>Disclosed are pharmaceutical composition comprising a (a) PNP inhibitor and (b) an alkylating agent. Also disclosed is the use of the composition in the treatment of hematologic cancer and a kit comprising (a) PNP inhibitor and (b) an alkylating agent and/or an anti-CD20 agent. An example of an PNP inhibitor is forodesine.</p>
申请公布号 NZ617989(A) 申请公布日期 2015.05.29
申请号 NZ20080617989 申请日期 2008.12.10
申请人 BIOCRYST PHARMACEUTICALS INC. 发明人 BREITFELD PHILIP;BANTIA SHANTA;BABU YARLAGADDA S.
分类号 A61K45/06;A61K31/4184;A61K31/4745;A61K35/00;A61K39/395;A61P35/02 主分类号 A61K45/06
代理机构 代理人
主权项
地址